Related Experiment Video
Updated: May 25, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Nonsynonymous variants in the SMAD6 gene predispose to congenital cardiovascular malformation
Huay L Tan1, Elise Glen, Ana Töpf
1Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.
Insights
Rare genetic variants in SMAD6, a bone morphogenetic protein (BMP) signaling inhibitor, predispose individuals to congenital cardiovascular malformations (CVM). This study identifies specific SMAD6 mutations impacting BMP signaling, linking them to CVM development.
Area of Science:
- Genetics
- Cardiovascular Biology
- Developmental Biology
Background:
- Congenital cardiovascular malformation (CVM) has a familial predisposition, but causative genetic factors remain largely unknown.
- The bone morphogenetic protein (BMP) signaling pathway plays a critical role in cardiac development.
Purpose of the Study:
- To investigate rare variants in BMP signaling pathway genes for association with CVM.
- To identify specific genetic variants in SMAD6 that may predispose to CVM.
Main Methods:
- Sequencing of BMPR1A, BMPR2, and SMAD6 genes in sporadic CVM cases.
- In vitro functional assays to assess the impact of identified SMAD6 variants on BMP signaling.
- Transcriptional reporter assays and osteogenic response assays were utilized.
Main Results:
- Three nonsynonymous variants (p.C484F, p.P415L, p.A325T) were identified in the SMAD6 gene.
- SMAD6 variants p.C484F and p.P415L demonstrated significantly reduced activity in inhibiting BMP signaling.
- The p.C484F variant showed a diminished capacity to inhibit BMP-induced osteogenic response.
Conclusions:
- Low-frequency deleterious variants in SMAD6 are associated with an increased risk of CVM.
- This study provides the first evidence linking genetic variations in SMAD6 to a human disease phenotype.
Abstract:
Congenital cardiovascular malformation (CVM) exhibits familial predisposition, but most of the specific genetic factors involved are unknown. Postulating that rare variants in genes in critical cardiac developmental pathways predispose to CVM, we systematically surveyed three genes of the bone morphogenetic protein (BMP) signaling pathway for novel variants. Exonic, splice site, and untranslated regions of BMPR1A, BMPR2, and SMAD6 genes were sequenced in 90 unrelated sporadic cases of CVM. One nonsynonymous variant (p.C484F) with predicted functional impact was found in the MAD homology 2 domain of SMAD6, an intracellular inhibitor of BMP signaling. Sequencing this domain in an additional 346 cases of CVM yielded two further nonsynonymous variants (p.P415L and p.A325T). Functional effects of all three SMAD6 mutations were investigated using BMP signaling assays in vitro. Two SMAD6 variants (p.C484F and p.P415L) had significantly (P < 0.05) lower activity than wild-type SMAD6 in inhibiting BMP signaling in a transcriptional reporter assay. In addition, the p.C484F variant had a significantly (P < 0.05) lower capacity to inhibit an osteogenic response to BMP signaling. We conclude that low-frequency deleterious variants in SMAD6 predispose to CVM. This is the first report of a human disease phenotype related to genetic variation in SMAD6.
Related Concept Videos
Pleiotropy
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Sex-linked Disorders
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...

